Eligard side effects - from FDA reports


Summary

In this review, we analyze Eligard side effects by the time on the drug, gender and age of the people who have side effects while taking Eligard. The review is based on 4,173 people who have side effects while taking the drug from FDA, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


Eligard

Eligard has active ingredients of leuprolide acetate. It is often used in prostate cancer. (latest outcomes from Eligard 4,198 users)

On Oct, 28, 2017

4,173 people who take Eligard are studied.


Number of reports submitted per year:

Eligard side effects.

Most common side effects over time *:

< 1 month:
  • prostatic specific antigen increased
  • drug ineffective
  • febrile neutropenia
  • death
  • pulmonary embolism
  • cardiac failure
  • alanine aminotransferase increased
  • hyperkalaemia
  • neutropenia
  • ventricular fibrillation
1 - 6 months:
  • death
  • terminal state
  • hot flush
  • prostatic specific antigen increased
  • small intestinal obstruction
  • toxic skin eruption
  • pulmonary embolism
  • drug ineffective
  • hospitalisation
  • pneumonia
6 - 12 months:
  • death
  • prostatic specific antigen increased
  • prothrombin time abnormal
  • weight increased
  • nausea
  • fatigue
  • hospitalisation
  • muscle disorder
  • phlebitis
  • pneumonia
1 - 2 years:
  • death
  • prostate cancer metastatic
  • cardiac arrest
  • hepatitis c
  • hospitalisation
  • malaise
  • myocardial infarction
  • oesophageal adenocarcinoma
  • prostatic specific antigen increased
  • ventricular extrasystoles
2 - 5 years:
  • death
  • hospitalisation
  • myocardial infarction
  • muscular weakness
  • oedema peripheral
  • prostate cancer metastatic
  • prostatic specific antigen increased
  • weight increased
  • anaemia
  • brain neoplasm malignant
5 - 10 years:
  • hip fracture
  • lung neoplasm malignant
  • malaise
  • death
  • hospitalisation
  • arterial occlusive disease
  • dementia
  • disease progression
  • ear neoplasm
  • functional gastrointestinal disorder
10+ years:
  • death
  • myocardial infarction
  • renal failure
not specified:
  • death
  • prostatic specific antigen increased
  • terminal state
  • hot flush
  • drug ineffective
  • hospitalisation
  • weight decreased
  • vomiting
  • osteonecrosis of jaw
  • pneumonia

Most common side effects by gender *:

female:
  • focal nodular hyperplasia
  • weight decreased
  • neoplasm progression
  • visual impairment
  • vomiting
  • brachial plexus injury
  • dehydration
  • elevated mood
  • injection site reaction
  • nausea
male:
  • death
  • prostatic specific antigen increased
  • terminal state
  • drug ineffective
  • hot flush
  • weight increased
  • weight decreased
  • injection site pain
  • osteonecrosis of jaw
  • hospitalisation

Most common side effects by age *:

0-1:
  • xerosis
2-9:
  • focal nodular hyperplasia
  • psoriasis
  • rash
30-39:
  • elevated mood
  • weight decreased
40-49:
  • confusional state
  • fungal infection
  • hair growth abnormal
  • injection site reaction
  • myalgia
  • renal failure
  • skin disorder
  • urinary tract obstruction
50-59:
  • death
  • drug ineffective
  • osteonecrosis of jaw
  • prostatic specific antigen increased
  • toxic optic neuropathy
  • alanine aminotransferase increased
  • hyperkalaemia
  • pulmonary embolism
  • terminal state
  • urethral haemorrhage
60+:
  • death
  • prostatic specific antigen increased
  • drug ineffective
  • hot flush
  • osteonecrosis of jaw
  • weight decreased
  • vomiting
  • hospitalisation
  • weight increased
  • pneumonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Are you taking Eligard?

Expand the study to include reports from both FDA and eHealthMe

Eligard side effects from FDA and eHealthMe reports

Related studies

All Eligard side effects from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Eligard (leuprolide acetate) is often used to treat prostate cancer. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

You may be interested in these reviews

More reviews for: Eligard